nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—PLA2G1B—blood plasma—hepatitis B	0.13	0.218	CbGeAlD
Niflumic Acid—CLCNKA—liver—hepatitis B	0.0944	0.158	CbGeAlD
Niflumic Acid—PLA2G4A—blood plasma—hepatitis B	0.0793	0.132	CbGeAlD
Niflumic Acid—PLA2G1B—blood—hepatitis B	0.0477	0.0797	CbGeAlD
Niflumic Acid—SLC16A7—blood—hepatitis B	0.0402	0.0671	CbGeAlD
Niflumic Acid—UGT1A9—Nicotine Metabolism—CYP2A6—hepatitis B	0.0366	0.0913	CbGpPWpGaD
Niflumic Acid—UGT1A9—liver—hepatitis B	0.0341	0.057	CbGeAlD
Niflumic Acid—SLC16A7—liver—hepatitis B	0.0314	0.0525	CbGeAlD
Niflumic Acid—PTGS1—blood plasma—hepatitis B	0.0313	0.0523	CbGeAlD
Niflumic Acid—PTGS2—blood plasma—hepatitis B	0.03	0.05	CbGeAlD
Niflumic Acid—PLA2G4A—blood—hepatitis B	0.0291	0.0485	CbGeAlD
Niflumic Acid—SLC16A1—liver—hepatitis B	0.02	0.0334	CbGeAlD
Niflumic Acid—PTGS1—Eicosanoid Synthesis—GGT2—hepatitis B	0.0163	0.0405	CbGpPWpGaD
Niflumic Acid—PTGS2—Eicosanoid Synthesis—GGT2—hepatitis B	0.0129	0.0322	CbGpPWpGaD
Niflumic Acid—PTGS1—blood—hepatitis B	0.0115	0.0192	CbGeAlD
Niflumic Acid—PTGS2—blood—hepatitis B	0.011	0.0183	CbGeAlD
Niflumic Acid—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—CYP2A6—hepatitis B	0.0108	0.027	CbGpPWpGaD
Niflumic Acid—UGT1A9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.0096	0.0239	CbGpPWpGaD
Niflumic Acid—PTGS2—liver—hepatitis B	0.00858	0.0143	CbGeAlD
Niflumic Acid—PTGS1—Eicosanoid Synthesis—GGT1—hepatitis B	0.00769	0.0192	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—ALPL—hepatitis B	0.00731	0.0182	CbGpPWpGaD
Niflumic Acid—UGT1A9—Phase II conjugation—GGT2—hepatitis B	0.00705	0.0176	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Arachidonic acid metabolism—GGT1—hepatitis B	0.00633	0.0158	CbGpPWpGaD
Niflumic Acid—PTGS2—Eicosanoid Synthesis—GGT1—hepatitis B	0.0061	0.0152	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—GGT2—hepatitis B	0.00575	0.0143	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—NOS2—hepatitis B	0.00533	0.0133	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—NFKB1—hepatitis B	0.00479	0.0119	CbGpPWpGaD
Niflumic Acid—UGT1A9—NRF2 pathway—GGT2—hepatitis B	0.0047	0.0117	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—GGT2—hepatitis B	0.00456	0.0114	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00438	0.0109	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—HBE1—hepatitis B	0.00437	0.0109	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—hepatitis B	0.00433	0.0108	CbGpPWpGaD
Niflumic Acid—PTGS1—Arachidonic acid metabolism—GGT1—hepatitis B	0.00427	0.0107	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metapathway biotransformation—AKR1B1—hepatitis B	0.00424	0.0106	CbGpPWpGaD
Niflumic Acid—UGT1A9—Biological oxidations—GGT2—hepatitis B	0.00413	0.0103	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—hepatitis B	0.00403	0.01	CbGpPWpGaD
Niflumic Acid—PTGS1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00384	0.00956	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—MIF—hepatitis B	0.00347	0.00866	CbGpPWpGaD
Niflumic Acid—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—hepatitis B	0.00341	0.0085	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—HBE1—hepatitis B	0.0034	0.00848	CbGpPWpGaD
Niflumic Acid—PTGS2—Arachidonic acid metabolism—GGT1—hepatitis B	0.00339	0.00846	CbGpPWpGaD
Niflumic Acid—PTGS1—Biological oxidations—GGT2—hepatitis B	0.00336	0.00839	CbGpPWpGaD
Niflumic Acid—UGT1A9—Phase II conjugation—GGT1—hepatitis B	0.00334	0.00832	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—NOS2—hepatitis B	0.00321	0.008	CbGpPWpGaD
Niflumic Acid—SLC16A1—Cell surface interactions at the vascular wall—F2—hepatitis B	0.00302	0.00752	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.00295	0.00736	CbGpPWpGaD
Niflumic Acid—CLCNKA—Transmembrane transport of small molecules—ALB—hepatitis B	0.00294	0.00734	CbGpPWpGaD
Niflumic Acid—PTGS1—Overview of nanoparticle effects—TNF—hepatitis B	0.00291	0.00726	CbGpPWpGaD
Niflumic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—hepatitis B	0.00286	0.00712	CbGpPWpGaD
Niflumic Acid—UGT1A9—NRF2 pathway—CYP2A6—hepatitis B	0.00285	0.00711	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet homeostasis—NOS2—hepatitis B	0.00281	0.007	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—hepatitis B	0.0028	0.00698	CbGpPWpGaD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.00272	0.00678	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—GGT1—hepatitis B	0.00272	0.00678	CbGpPWpGaD
Niflumic Acid—SLC16A7—SLC-mediated transmembrane transport—ALB—hepatitis B	0.00271	0.00676	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—hepatitis B	0.0026	0.00649	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—hepatitis B	0.00255	0.00635	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Phospholipid metabolism—PTEN—hepatitis B	0.00251	0.00625	CbGpPWpGaD
Niflumic Acid—UGT1A9—Biological oxidations—CYP2A6—hepatitis B	0.0025	0.00623	CbGpPWpGaD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.00242	0.00603	CbGpPWpGaD
Niflumic Acid—PTGS1—Overview of nanoparticle effects—IL6—hepatitis B	0.00235	0.00586	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—hepatitis B	0.00233	0.00581	CbGpPWpGaD
Niflumic Acid—PTGS2—Overview of nanoparticle effects—TNF—hepatitis B	0.00231	0.00576	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—HSPA5—hepatitis B	0.00228	0.0057	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—hepatitis B	0.00226	0.00564	CbGpPWpGaD
Niflumic Acid—UGT1A9—NRF2 pathway—GGT1—hepatitis B	0.00223	0.00555	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—NFKB1—hepatitis B	0.00218	0.00543	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—GGT1—hepatitis B	0.00216	0.00538	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—NFKB1—hepatitis B	0.00205	0.0051	CbGpPWpGaD
Niflumic Acid—PTGS1—Biological oxidations—CYP2A6—hepatitis B	0.00204	0.00508	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00199	0.00497	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.00199	0.00496	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—AKR1B1—hepatitis B	0.00195	0.00487	CbGpPWpGaD
Niflumic Acid—UGT1A9—Biological oxidations—GGT1—hepatitis B	0.00195	0.00487	CbGpPWpGaD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.00189	0.0047	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GGT2—hepatitis B	0.00187	0.00467	CbGpPWpGaD
Niflumic Acid—PTGS2—Overview of nanoparticle effects—IL6—hepatitis B	0.00187	0.00465	CbGpPWpGaD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.00176	0.00439	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—F2—hepatitis B	0.00174	0.00434	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.00166	0.00414	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00165	0.00412	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—hepatitis B	0.00165	0.00411	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—CXCL10—hepatitis B	0.00164	0.0041	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.0016	0.004	CbGpPWpGaD
Niflumic Acid—PTGS1—Biological oxidations—GGT1—hepatitis B	0.00159	0.00397	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.00158	0.00394	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—HSPA5—hepatitis B	0.00151	0.00377	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.00148	0.00368	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.00147	0.00365	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—hepatitis B	0.00146	0.00365	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—ALB—hepatitis B	0.00145	0.00361	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—F2—hepatitis B	0.00138	0.00345	CbGpPWpGaD
Niflumic Acid—SLC16A7—Transmembrane transport of small molecules—ALB—hepatitis B	0.00138	0.00344	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IFNB1—hepatitis B	0.00137	0.0034	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00135	0.00336	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IFNA1—hepatitis B	0.00133	0.00332	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—IFNG—hepatitis B	0.00132	0.00329	CbGpPWpGaD
Niflumic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—hepatitis B	0.00125	0.00312	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IFNA2—hepatitis B	0.00124	0.00309	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—F2—hepatitis B	0.00123	0.00308	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—PTEN—hepatitis B	0.00123	0.00308	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—HSPA5—hepatitis B	0.00118	0.00294	CbGpPWpGaD
Niflumic Acid—SLC16A1—SLC-mediated transmembrane transport—ALB—hepatitis B	0.00116	0.00289	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—ALB—hepatitis B	0.00115	0.00286	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—AKR1B1—hepatitis B	0.00114	0.00285	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Phospholipid metabolism—PTEN—hepatitis B	0.00114	0.00284	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.00114	0.00284	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TLR4—hepatitis B	0.00114	0.00283	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CYP2A6—hepatitis B	0.00113	0.00283	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—CDKN2A—hepatitis B	0.00112	0.00278	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—NFKB1—hepatitis B	0.0011	0.00274	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GGT2—hepatitis B	0.0011	0.00273	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—NOS2—hepatitis B	0.00108	0.00269	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00107	0.00267	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—hepatitis B	0.00107	0.00266	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IFNB1—hepatitis B	0.00106	0.00265	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.00106	0.00264	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—CD4—hepatitis B	0.00105	0.00262	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IFNG—hepatitis B	0.00105	0.00261	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IFNA1—hepatitis B	0.00104	0.00258	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GOT2—hepatitis B	0.00103	0.00256	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—ALB—hepatitis B	0.00103	0.00256	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IFNA2—hepatitis B	0.000964	0.0024	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—CDKN1A—hepatitis B	0.000911	0.00227	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000904	0.00225	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000902	0.00225	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000891	0.00222	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—AKR1B1—hepatitis B	0.000888	0.00221	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GOT1—hepatitis B	0.000885	0.00221	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GGT1—hepatitis B	0.000885	0.00221	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000881	0.0022	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000879	0.00219	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000875	0.00218	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—NFKB1—hepatitis B	0.000872	0.00217	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000859	0.00214	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—TNF—hepatitis B	0.000854	0.00213	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GGT2—hepatitis B	0.000852	0.00212	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—IL2—hepatitis B	0.000831	0.00207	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IFNG—hepatitis B	0.000829	0.00207	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SAG—hepatitis B	0.000821	0.00205	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RIT2—hepatitis B	0.000821	0.00205	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—F2—hepatitis B	0.000818	0.00204	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—NOS2—hepatitis B	0.000808	0.00202	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000807	0.00201	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000749	0.00187	CbGpPWpGaD
Niflumic Acid—UGT1A9—NRF2 pathway—TGFB1—hepatitis B	0.000749	0.00187	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL2—hepatitis B	0.000736	0.00184	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—AKR1B1—hepatitis B	0.000736	0.00183	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000729	0.00182	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GGT2—hepatitis B	0.000706	0.00176	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—IL6—hepatitis B	0.000689	0.00172	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.00068	0.0017	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—ALB—hepatitis B	0.000679	0.00169	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—TNF—hepatitis B	0.000678	0.00169	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP2A6—hepatitis B	0.000663	0.00165	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	0.000648	0.00162	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—F2—hepatitis B	0.000636	0.00159	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SAG—hepatitis B	0.000629	0.00157	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOBEC3G—hepatitis B	0.000629	0.00157	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—NOS2—hepatitis B	0.000629	0.00157	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000611	0.00152	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AKR1B1—hepatitis B	0.0006	0.0015	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GOT2—hepatitis B	0.0006	0.0015	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.0006	0.0015	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—ALB—hepatitis B	0.000588	0.00147	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GGT2—hepatitis B	0.000575	0.00143	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TGFB1—hepatitis B	0.000574	0.00143	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IL2—hepatitis B	0.000551	0.00137	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCL10—hepatitis B	0.000549	0.00137	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IL6—hepatitis B	0.000547	0.00136	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TNF—hepatitis B	0.000536	0.00134	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—ALB—hepatitis B	0.000528	0.00132	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GOT1—hepatitis B	0.000518	0.00129	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GGT1—hepatitis B	0.000518	0.00129	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP2A6—hepatitis B	0.000516	0.00129	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000485	0.00121	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000484	0.00121	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000481	0.0012	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AKR1B1—hepatitis B	0.000476	0.00119	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TP53—hepatitis B	0.000473	0.00118	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000472	0.00118	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000471	0.00118	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—ALB—hepatitis B	0.000471	0.00117	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000469	0.00117	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GOT2—hepatitis B	0.000467	0.00116	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GGT2—hepatitis B	0.000457	0.00114	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL6—hepatitis B	0.000433	0.00108	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TGFB1—hepatitis B	0.00043	0.00107	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IL2—hepatitis B	0.000428	0.00107	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP2A6—hepatitis B	0.000428	0.00107	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CCR5—hepatitis B	0.000426	0.00106	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GGT1—hepatitis B	0.000403	0.001	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GOT1—hepatitis B	0.000403	0.001	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000399	0.000994	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000391	0.000974	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GOT2—hepatitis B	0.000387	0.000964	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000367	0.000915	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—F2—hepatitis B	0.000365	0.00091	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000365	0.00091	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTEN—hepatitis B	0.000359	0.000896	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TP53—hepatitis B	0.000354	0.000882	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP2A6—hepatitis B	0.000349	0.000869	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TGFB1—hepatitis B	0.000334	0.000833	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GOT1—hepatitis B	0.000334	0.000832	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GGT1—hepatitis B	0.000334	0.000832	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000325	0.00081	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCL10—hepatitis B	0.000324	0.000808	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000322	0.000802	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GOT2—hepatitis B	0.000315	0.000786	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000304	0.000758	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—GOT2—hepatitis B	0.000299	0.000745	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP2A6—hepatitis B	0.000277	0.00069	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ALB—hepatitis B	0.000275	0.000687	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TP53—hepatitis B	0.000275	0.000686	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GOT1—hepatitis B	0.000272	0.000678	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GGT1—hepatitis B	0.000272	0.000678	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000258	0.000643	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—GOT1—hepatitis B	0.000258	0.000643	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCR5—hepatitis B	0.000251	0.000627	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GOT2—hepatitis B	0.00025	0.000624	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000248	0.000618	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL2—hepatitis B	0.000246	0.000613	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GOT1—hepatitis B	0.000216	0.000538	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GGT1—hepatitis B	0.000216	0.000538	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—F2—hepatitis B	0.000216	0.000538	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ALB—hepatitis B	0.000214	0.000534	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTEN—hepatitis B	0.00021	0.000524	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000197	0.000491	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CCR5—hepatitis B	0.000193	0.00048	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HLA-A—hepatitis B	0.000188	0.000468	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ALB—hepatitis B	0.000178	0.000443	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTEN—hepatitis B	0.000163	0.000408	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS2—hepatitis B	0.000163	0.000407	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL2—hepatitis B	0.000145	0.000362	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALB—hepatitis B	0.000145	0.000361	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6—hepatitis B	0.000145	0.00036	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CTNNB1—hepatitis B	0.00014	0.00035	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CDKN1A—hepatitis B	0.000137	0.000342	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTEN—hepatitis B	0.000137	0.000341	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NFKB1—hepatitis B	0.000136	0.000339	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTEN—hepatitis B	0.000135	0.000338	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CD4—hepatitis B	0.000121	0.000301	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALB—hepatitis B	0.000115	0.000286	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TGFB1—hepatitis B	0.000113	0.000283	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTEN—hepatitis B	0.00011	0.000275	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CTNNB1—hepatitis B	0.000107	0.000268	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CDKN1A—hepatitis B	0.000105	0.000262	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PTEN—hepatitis B	0.000105	0.000261	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TP53—hepatitis B	9.33e-05	0.000233	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PTEN—hepatitis B	8.77e-05	0.000219	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TGFB1—hepatitis B	8.68e-05	0.000216	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6—hepatitis B	8.54e-05	0.000213	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6—hepatitis B	6.54e-05	0.000163	CbGpPWpGaD
